SUSANNA E. BEDELL, M.D.
This content is PDF only. Please click on the PDF icon to access.
To the editor: Delta9-tetrahydrocannabinol, commonly known as marijuana, has been extensively mystified, mythologized, and politicized during the 20th century. The scientific review by Dr. Tashkin and co-authors (Ann Intern Med 89:539-549, 1978) offers hope for a more rigorous, cautious, and clinically relevant use for cannabis. Although this excellent discussion is optimistic in its anticipation of the future for cannabis in clinical medicine, it is flawed by its limited appreciation of the research already showing delta9-tetrahydrocannabinol to be beneficial for some groups of human subjects. Dr. Tashkin's statement that the "potential therapeutic properties [of cannabis] were gradually forgotten" during the 20th
BEDELL SE. Cannabis and Cancer Chemotherapy. Ann Intern Med. 1979;90:276. doi: 10.7326/0003-4819-90-2-276_1
Download citation file:
Published: Ann Intern Med. 1979;90(2):276.
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use